graphically, the province consists of a peninsula attached to mainland Canada by a narrow isthmus. Pediatric neurosurgery services in Nova Scotia are provided at a single institution, the IWK Health Centre in Halifax. All patients in whom LMM is diagnosed are seen at this center, and findings in these cases are entered into the Spina Bifida Clinic database. This database began recording all diagnoses of spinal dysraphism at the IWK Health Centre in 1985 and it was used to identify our LMM cases. The patient's date of birth was used as the index year in which the case occurred.
Inclusion criteria required the diagnosis of LMM confirmed by operative findings. Patients were included if they were born in Nova Scotia between January 1, 1985, and December 31, 2001 .
Incidence rates and CIs were calculated using the total number of patients born with an LMM during a given period and the total number of live births during that epoch. We considered the years 1985 to 1994 to be the period prior to the recommendation of folic acid supplementation; the years 1995 to 1998 to be the period during which dietary supplementation was being recommended, but prior to its fortification in the food supply; and finally, the years 1999 to 2001 to be the period after fortification was instituted.
Statistical calculations were performed using SPSS for Windows (version 11.0.1; SPSS, Inc., Chicago, IL). Descriptive statistics were tabulated, and comparisons of means between groups were performed and expressed as RR ratios with 95% CIs. Chi-square analysis was used to calculate statistical significance. Results were considered significant at a probability value less than 0.05.
Results
During the overall study period (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) , there were 31 cases of LMM identified and 189,752 live births recorded in the province of Nova Scotia, yielding an overall incidence of 16 per 100,000 live births, or one case per 6121 live births (Table 1) . In this cohort, 20 (65%) of 31 patients were female.
The mean annual incidence of LMM between 1985 and 1994 was 15 per 100,000 live births, and between 1995 and 1998 it was 12 per 100,000 live births (RR 0.82, 95% CI 0.31-2.22; p = 0.7). During the period from 1999 to 2001, the mean annual incidence of LMM was 29 per 100,000 live births, which was not significantly different from that during the period 1995 to 1998 (RR 2.41, 95% CI 0.79-7.36; p = 0.11) or from 1985 to 1994 (RR 1.98, 95% CI 0.86-4.56; p = 0.1). There was in fact a trend toward increasing incidence of LMM over time, which did not reach statistical significance.
Discussion
In the present study we demonstrated for the first time that public policies encouraging periconceptual folic acid supplementation and eventually mandating fortification of the food supply have not had a significant impact on the incidence of LMM. The relationship between occult forms of spina bifida and open NTDs remains uncertain. 7 The embryogenesis of LMM is not known with certainty but may involve premature focal dysjunction of neural ectoderm from cutaneous ectoderm during the process of primary neurulation. 13, 14 This would allow migration of periaxial mesoderm into the developing neural tube and lead to posterior myeloschisis. The finding that dietary folic acid supplementation does not reduce the incidence of LMM is evidence that the pathogenesis of LMM is fundamentally different from that of myelomeningocele.
The overall incidence of LMM in Nova Scotia during the study period (1985-2001) was 16 per 100,000 live births. To our knowledge, this is the first population-based study to calculate the incidence of this condition. Other authors have estimated the incidence as approximately one case per 4000 births. 11, 14 This estimate appears to be based on the known incidence of myelomeningoceles (one case/1000 births) 9 coupled with the observation that LMM seemed to occur with an incidence of 25% that of myelomeningoceles. 17 The preponderance of affected female patients in our study has been noted in previous series. 8, 11, 12, 17 Documentation of the epidemiology of LMM is likely to be useful to future investigators conducting studies of this condition.
The strengths of this study include Nova Scotia's unique geography and the nature of healthcare delivery in this province. Accurate population statistics are readily available, and all pediatric neurosurgery services are located at a single institution. This provides us with the unique opportunity of obtaining accurate populationbased information. The limitation of this study is that identification of LMM cases was dependent on patient referral to neurosurgical care. It is possible that some asymptomatic patients are never referred for neurosurgical attention. Improving access to magnetic resonance imaging and increasing awareness of this problem may be responsible for the trend toward the higher incidence of LMM over time noted in the present cohort of patients.
Conclusions
The overall incidence of LMM in Nova Scotia between 1985 and 2001 was 16 per 100,000 live births (one case per 6121 live births). This incidence has not been reduced by public policies encouraging dietary folic acid supple- 
